Leading brokers name 3 ASX shares to sell today

Here's why brokers are bearish on these ASX shares…

Yesterday I looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on these ASX shares:

Business man marking Sell on board and underlining it

Image Source: Getty Images

A2 Milk Company Ltd (ASX: A2M)

According to a note out of Credit Suisse, its analysts have retained their underperform rating and $5.50 price target on this infant formula company's shares. The broker notes that infant formula prices stabilised in September. It also highlights that marketing activity is increasing ahead of the major Double 11 shopping event in China. However, Credit Suisse appears to believe it is too soon to get excited and holds firm with its underperform rating. The A2 Milk share price is fetching $6.11 on Wednesday.

Fortescue Metals Group Limited (ASX: FMG)

A note out of Goldman Sachs reveals that its analysts have retained their sell rating and cut their price target down to a lowly $11.40. The broker is particularly bearish on low grade iron ore prices and feels the miner's shares are overvalued at the current level. This is particularly the case in comparison to some of its iron ore peers. The Fortescue share price is trading at $14.09 this afternoon.

Unibail-Rodamco-Westfield CDI (ASX: URW)

Analysts at Ord Minnett have retained their sell rating and $4.00 price target on this shopping centre operator's shares. According to the note, the broker acknowledges that the company's shares have pulled back meaningfully in recent months. However, it still doesn't see enough value in its shares or proof that a rebound in trading conditions is taking place. In light of this, it holds firm with its sell rating for now. The Unibail-Rodamco-Westfield share price is trading at $4.92 today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Cleanaway Waste Management, New Hope Corporation, CSL shares

Let's check out some new ratings on ASX shares today.

Read more »

Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market
Broker Notes

3 ASX 200 shares to buy and why: Ord Minnett

The top broker explains its buy recommendations on Fortescue, ARB, and Resmed shares.

Read more »

Piggybank with an army helmet and a drone next to it, symbolising a rising DroneShield share price.
Broker Notes

How high will DroneShield shares go? A broker weighs in

While volatile, the signs are good for this company, Canaccord Genuity says.

Read more »

Woman with her hands out to each side on a light blue background.
Broker Notes

Buy, hold, sell: Ramelius Resources, Medibank, Soul Patts shares

Let's take a look at some new ratings from the experts this week.

Read more »

Two colleagues looking at a graph and comparing share prices.
Broker Notes

Guess which ASX 200 share was just hit with a broker downgrade

Bell Potter has turned lukewarm on this popular stock.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

This ASX uranium company is set to surge: Brokers

Despite a project delay this company's shares look cheap, brokers agree.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares UBS has tipped to increase 44% to 76%

Three very different companies to choose from.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Broker Notes

Morgan Stanley just upgraded their CSL share price target

The blood products company is still looking like a good buy.

Read more »